Table 1.
SRP | UC | Total | |
---|---|---|---|
Characteristics | n = 204 | n = 210 | N = 414 |
M (SD) or (N, %) | M (SD) or (N, %) | M (SD) or (N, %) | |
Gender (Female) | 102 (50.0%) | 106 (51.0%) | 208 (50.2%) |
Age | 55.0 (11.0) | 55.0 (10.5) | 55.0 (10.7) |
Race | |||
White | 193 (95.0%) | 189 (90.0%) | 382 (92.3%) |
Black/African American | 3 (1.0%) | 10 (5.0%) | 13 (3.1%) |
Other | 4 (2.0%) | 7 (3.0%) | 11 (2.7%) |
Hispanic ethnicity | 13 (6.0%) | 16 (8.0%) | 29 (7.0%) |
Marital Status: Married or living with a partner | 113 (55.0%) | 111 (53.0%) | 224 (54.0%) |
Education: High school graduate or below | 94 (46.0%) | 96 (46.0%) | 190 (46.0%) |
Income: Below $30,000/year | 84 (41.0%) | 86 (41.0%) | 170 (41.0%) |
Employed | 117 (57.0%) | 112 (53.3%) | 229 (55.3%) |
Financial concerns regarding cancer Dx/Tx: Yes | 122 (59.8%) | 128 (60.9%) | 250 (60.3%) |
Current financial situation | |||
Difficult/Very Difficult | 58 (28.4%) | 58 (27.6%) | 116 (28.0%) |
Cancer Site | |||
Thoracic | 43 (21.1%) | 45 (21.4%) | 88 (21.3%) |
Head &Neck | 38 (18.6%) | 38 (18.1%) | 76 (18.4%) |
Gastrointestinal | 25 (12.3%) | 26 (12.4%) | 51 (12.3%) |
Genitourinary | 26 (12.8%) | 17 (8.1%) | 43 (10.4%) |
Breast | 22 (10.8%) | 26 (12.4%) | 47 (11.6%) |
Gynecological | 20 (9.8%) | 16 (7.6%) | 36 (8.7%) |
Hematological | 16 (7.8%) | 25 (11.9%) | 41 (9.9%) |
Cutaneous | 10 (4.9%) | 10 (4.8%) | 20 (4.8%) |
Other | 4 (2.0%) | 7 (3.3%) | 11 (2.7%) |
Disease stage (TNM) | |||
Unstaged | 20 (9.8%) | 38 (18.1%) | 58 (14.0%) |
Stage 0 | 7 (3.4%) | 2 (1.0%) | 9 (2.2%) |
Early (I–II) | 111 (54.4%) | 90 (42.9%) | 201 (48.6%) |
Late (III–IV) | 66 (32.4%) | 80 (38.1%) | 146 (35.3%) |
Smoking-related variables | |||
Cigarettes per day | 21.6 (9.4) | 20.3 (9.6) | 21.0 (9.5) |
Number of years smoking | 35.0 (12.6) | 34.3 (11.5) | 34.6 (12.1) |
Fagerström Test for Nicotine Dependence | 5.3 (2.1) | 5.0 (2.2) | 5.1 (2.2) |
Quitting self-efficacy | 37.9 (7.6) | 38.4 (7.5) | 38.2 (7.6) |